Evidence Report/Technology Assessment Number 69

Management of Bronchiolitis in Infants and Children

File Inventory


Prepared by:

RTI International-University of North Carolina
Evidence-based Practice Center

Meera Viswanathan, Ph.D.
Valerie J. King, M.D., M.P.H.
Clay Bordley, M.D., M.P.H.
Amanda A. Honeycutt, Ph.D.
John Wittenborn, B.A., B.S.
Anne M. Jackman, M.S.W.
Sonya F. Sutton, B.S.P.H.
Kathleen N. Lohr, Ph.D.


File Name	Description			Software	Version		File	Size
________________________________________________________________________________________________
01front.doc	Microsoft Word® Document	MS Word®	2002		51KB	5 pages
Contents: Cover, Title Page, Preface
________________________________________________________________________________________________
02ackn.doc	Microsoft Word® Document	MS Word®	2002		126KB	1 page
Contents: Acknowledgments
________________________________________________________________________________________________
03abstr.doc	Microsoft Word® Document	MS Word®	2002		132KB	2pages
Contents: Structured Abstract
________________________________________________________________________________________________
04conts.doc	Microsoft Word® Document	MS Word®	2002		121KB	4pages
Contents: Table of Contents
________________________________________________________________________________________________
05summ.doc	Microsoft Word® Document	MS Word®	2002		154KB	8 pages
Contents: Summary: Overview, Reporting the Evidence, Methodology, Findings, Future Research
________________________________________________________________________________________________
06chap1.doc	Microsoft Word® Document	MS Word®	2002		164KB	8 pages
Contents: Chapter 1. Introduction: Background, Clinical Issues, Justification for this 
Evidence Report, Key Questions and Causal Pathways, Organization of this Report
________________________________________________________________________________________________
07fig1.doc	Microsoft Word® Document	MS Word®	2002		132KB	1 page
Contents: Figure 1. Diagnosis and Treatment of Bronchiolitis Among Infants and Children
________________________________________________________________________________________________
08fig2.doc	Microsoft Word® Document	MS Word®	2002		133KB	1 page
Contents: Figure 2. Effectiveness and Costs of Respiratory Syncytial Virus Prophylaxis 
of Bronchiolitis for Infants and Children
________________________________________________________________________________________________
09chap2.doc	Microsoft Word® Document	MS Word®	2002		161KB	8 pages
Contents: Chapter 2. Methodology: Literature Review Methods, Data Collection, Analysis Strategy
________________________________________________________________________________________________
10tbl1.doc	Microsoft Word® Document	MS Word®	2002		132KB	1 page
Contents: Table 1. Management of Bronchiolitis in Infants and Children:  Inclusion and 
Exclusion Criteria
________________________________________________________________________________________________
11tbl2.doc	Microsoft Word® Document	MS Word®	2002		134KB	1 page
Contents: Table 2. Management of Bronchiolitis in Infants and Children: Search Terms
________________________________________________________________________________________________
12tbl3.doc	Microsoft Word® Document	MS Word®	2002		131KB	1 page
Contents: Table 3. Electronic Databases for Literature Searches
________________________________________________________________________________________________
13fig3.doc	Microsoft Word® Document	MS Word®	2002		150KB	1 page
Contents: Figure 3. Cost Effectiveness Decision Tree
________________________________________________________________________________________________
14chap3.doc	Microsoft Word® Document	MS Word®	2002		378KB	33 pages
Contents: Chapter 3. Results: Key Question 1: Effectiveness of Diagnostic Tools for Diagnosing 
Bronchiolitis in Infants and Children
________________________________________________________________________________________________
15tbl4.doc	Microsoft Word® Document	MS Word®	2002		139KB	1 page
Contents: Table 4. Studies Examining the Accuracy of Virologic Tests
________________________________________________________________________________________________
16tbl5.doc	Microsoft Word® Document	MS Word®	2002		149KB	2 pages
Contents: Table 5. Studies Measuring Predictors of Disease Severity
________________________________________________________________________________________________
17tbl6.doc	Microsoft Word® Document	MS Word®	2002		163KB	3 pages
Contents: Table 6. Use of Chest X-rays for Diagnosis of Bronchiolitis
________________________________________________________________________________________________
18tbl7.doc	Microsoft Word® Document	MS Word®	2002		149KB	1 page
Contents: Table 7. Studies Examining Complete Blood Counts Performed
________________________________________________________________________________________________
19tbl8.doc	Microsoft Word® Document	MS Word®	2002		182KB	1 page
Contents: Table 8. Results of IMpact RSV Trial
________________________________________________________________________________________________
20tbl9.doc	Microsoft Word® Document	MS Word®	2002		200KB	2 pages
Contents: Table 9. RSV Hospitalization Rates
________________________________________________________________________________________________
21tbl10.doc	Microsoft Word® Document	MS Word®	2002		142KB	1 page
Contents: Table 10. Cost Estimates Used in Analyses
________________________________________________________________________________________________
22tbl11.doc	Microsoft Word® Document	MS Word®	2002		141KB	1 page
Contents: Table 11. 2001 Cost Per Hospitalization Avoided
________________________________________________________________________________________________
23chap4.doc	Microsoft Word® Document	MS Word®	2002		166KB	6 pages
Contents: Chapter 4. Conclusions: Diagnosis, Treatment, Prophylactic Therapy, 
Racial and Ethnic Subpopulations
________________________________________________________________________________________________
24tbl12.doc	Microsoft Word® Document	MS Word®	2002		174KB	2 pages
Contents: Table 12. Summary of Evidence for Treatment of Bronchiolitis
________________________________________________________________________________________________
25tbl13.doc	Microsoft Word® Document	MS Word®	2002		142KB	1 page
Contents: Table 13. Summary of Evidence for Prophylaxis of Bronchiolitis
________________________________________________________________________________________________
26chap5.doc	Microsoft Word® Document	MS Word®	2002		135KB	5 pages
Contents: Chapter 5. Future Research: Priorities for Further Research, General Guidelines 
for Further Research
________________________________________________________________________________________________
27refs.doc	Microsoft Word® Document	MS Word®	2002		164KB	8 pages
Contents: References
________________________________________________________________________________________________
28gloss.doc	Microsoft Word® Document	MS Word®	2002		187KB	4 pages
Contents: Glossary for Evidence Tables
________________________________________________________________________________________________
29etbls.doc	Microsoft Word® Document	MS Word®	2002		1.5MB	148 pages
Contents: Evidence Tables:
Evidence Table 1. Nebulized Epinephrine vs. Nebulized Saline Placebo
Evidence Table 2. Subcutaneous Epinephrine vs. Saline Placebo
Evidence Table 3. Nebulized Epinephrine vs. Nebulized Bronchodilators (Salbutamol or Albuterol)
Evidence Table 4. Nebulized Bronchodilators (Salbutamol or Albuterol) vs. Oral Bronchodilators, 
Nebulized Ipratropium Bromide, or Saline Placebo or No Treatment
Evidence Table 5. Nebulized Salbutamol or Albuterol plus Nebulized Ipratropium Bromide 
vs. Bronchodilators or Ipratropium Bromide Alone and/or Saline Placebo
Evidence Table 6. Oral Corticosteroids vs. Placebo, With or Without Bronchodilators
Evidence Table 7. Parenteral Dexamethasone vs. Placebo
Evidence Table 8. Nebulized Corticosteroids vs. Placebo or Usual Care
Evidence Table 9. Ribavirin vs. Placebo
Evidence Table 10. Antibiotics vs. No Treatment or Other Antibiotics
Evidence Table 11. RSVIG IV as Treatment for Bronchiolitis
Evidence Table 12. Other Miscellaneous Treatments for Bronchiolitis
Evidence Table 13. RSVIG IV vs. Placebo or Standard Care to Prevent RSV Bronchiolitis
Evidence Table 14. Monoclonal Antibody for Prophylaxis of RSV Bronchiolitis
Evidence Table 15. Vaccines to Prevent RSV Bronchiolitis
________________________________________________________________________________________________
30appa.doc	Microsoft Word® Document	MS Word®	2002		268KB	18 pages
Contents: Appendix A. Clinical Scales
________________________________________________________________________________________________
31appb.doc	Microsoft Word® Document	MS Word®	2002		143KB	4 pages
Contents: Appendix B. Abstract Review Form
________________________________________________________________________________________________
32appc.doc	Microsoft Word® Document	MS Word®	2002		592KB	48 pages
Contents: Appendix C. Final Abstraction Forms
________________________________________________________________________________________________
33appd.doc	Microsoft Word® Document	MS Word®	2002		148KB	4 pages
Contents: Appendix D. Quality Rating Form
________________________________________________________________________________________________

AHRQ Publication No. 03-E014
Current as of January 2003


Internet Citation:

Management of Bronchiolitis in Infants and Children. File Inventory, Evidence Report/Technology Assessment Number 69. AHRQ Publication No. 03-E014, January 2003. Agency for Healthcare Research and Quality, Rockville, MD. http://www.ahrq.gov/clinic/broncinv.htm


Return to Evidence-based Practice
Clinical Information
AHRQ Home Page
Department of Health and Human Services